BIONET Therapeutics Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	99.52	21.97	45.3	53.97
Short-Term Investments	936	1,155	458	-
Trading Asset Securities	24.45	37.72	21.02	-
Cash & Short-Term Investments	1,060	1,215	524.32	53.97
Cash Growth	-12.74%	131.67%	871.44%	-
Accounts Receivable	27.57	15.11	1.17	-
Other Receivables	8.23	6.59	1.6	-
Receivables	35.8	21.7	2.77	-
Inventory	30.08	29.52	0.37	-
Prepaid Expenses	11.87	8.98	0.89	0.15
Other Current Assets	0.09	0.09	-	-
Total Current Assets	1,138	1,275	528.35	54.12
Property, Plant & Equipment	138.51	54.22	8.72	-
Long-Term Investments	2.75	4.92	-	-
Other Intangible Assets	2.83	0.36	-	-
Other Long-Term Assets	1.18	15.55	3.11	-
Total Assets	1,283	1,350	540.18	54.12
Accounts Payable	7.97	16.84	5.23	0.68
Accrued Expenses	25.8	13.56	3.39	4.65
Current Portion of Leases	1.02	-	-	-
Current Unearned Revenue	11.3	4.32	2.61	-
Other Current Liabilities	11.68	18.98	0.86	0.09
Total Current Liabilities	57.77	53.7	12.09	5.42
Long-Term Leases	9.88	-	-	-
Total Liabilities	67.65	53.7	12.09	5.42
Common Stock	700	700	450.29	56
Additional Paid-In Capital	712.7	716.29	124.86	-
Retained Earnings	-231.12	-133.7	-47.44	-7.3
Comprehensive Income & Other	33.83	13.73	0.38	-
Shareholders' Equity	1,215	1,296	528.09	48.7
Total Liabilities & Equity	1,283	1,350	540.18	54.12
Total Debt	10.9	-	-	-
Net Cash (Debt)	1,049	1,215	524.32	53.97
Net Cash Growth	-13.63%	131.67%	871.44%	-
Net Cash Per Share	14.99	21.15	34.74	49.29
Filing Date Shares Outstanding	70	70	70	1.1
Total Common Shares Outstanding	70	70	45.03	1.1
Working Capital	1,080	1,221	516.26	48.7
Book Value Per Share	17.36	18.52	11.73	44.47
Tangible Book Value	1,213	1,296	528.09	48.7
Tangible Book Value Per Share	17.32	18.51	11.73	44.47
Machinery	88.24	35.34	9.3	-
Construction In Progress	-	22.6	-	-
Leasehold Improvements	53.87	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.